Comparative cost-effectiveness of focal and total salvage (125)I brachytherapy for recurrent prostate cancer after primary radiotherapy

PURPOSE: Focal salvage (FS) iodine 125 ((125)I) brachytherapy could be an effective treatment for locally radiorecurrent prostate cancer (PCa). Toxicity is often reduced compared to total salvage (TS) while cancer control can be maintained, which could increase cost-effectiveness. The current study...

Descripción completa

Detalles Bibliográficos
Autores principales: Peters, Max, Piena, Marjanne A., Steuten, Lotte M.G., van der Voort van Zyp, Jochem R.N., Moerland, Marinus A., van Vulpen, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2016
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5241382/
https://www.ncbi.nlm.nih.gov/pubmed/28115953
http://dx.doi.org/10.5114/jcb.2016.64808

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5241382/
https://www.ncbi.nlm.nih.gov/pubmed/28115953
http://dx.doi.org/10.5114/jcb.2016.64808

Ejemplares similares